This topic contains a solution. Click here to go to the answer

Author Question: A patient with a terminal illness says that when the pain becomes too unbearable he plans to take an ... (Read 91 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
A patient with a terminal illness says that when the pain becomes too unbearable he plans to take an overdose of pain medication and end it all. How should the nurse respond to this patient's plan?
 
  Select all that apply.
 
  1. Do you have a living will?
  2. Have you assigned durable power of attorney to anyone?
  3. Have you considered a healthcare surrogate?
  4. Have you researched methods for self-euthanasia?
  5. Have you talked with your healthcare provider about orders for life-sustaining treatment?

Question 2

A preoperative patient says to the nurse, I hope I wake up after surgery. I don't know what my family would do if I didn't. The nurse realizes this patient is demonstrating which potential problem?
 
  1. coping
  2. chronic sorrow
  3. anticipatory grieving
  4. death anxiety



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fraziera112

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

Correct Answer: 1, 2, 3, 5

A living will is a document that provides written directions about life-prolonging procedures to follow when an individual can no longer communicate in a life-threatening situation. Durable power of attorney is a document that can delegate the authority to make healthcare decisions. A healthcare surrogate is a person selected to make medical decisions when the patient is no longer able to do so. A physician order for life-sustaining treatment (POLST) is a form for patients with serious, progressive, chronic illnesses that translates their wishes regarding life-sustaining treatment into actionable medical orders. Euthanasia is not supported by the American Nurses Association and would be inappropriate to discuss with the patient.

Answer to Question 2

Correct Answer: 3

Anticipatory grieving is a combination of intellectual and emotional responses and behavior by which people adjust their self-concept in the face of a potential loss. This patient is expressing a feeling, not demonstrating coping. This patient is not demonstrating chronic sorrow, which is a cyclical, recurring, and potentially progressive pattern of pervasive sadness experienced in response to continual loss, throughout the trajectory of an illness or disability. This patient is not experiencing death anxiety, which is worry or fear related to death or dying. It may be present in patients who have an acute life-threatening illness, who have a terminal illness, who have experienced the death of a family member or friend, or who have experienced multiple deaths in the same family.




sabina

  • Member
  • Posts: 563
Reply 2 on: Jun 25, 2018
Thanks for the timely response, appreciate it


dyrone

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library